Characteristics and prognostic value of pleural effusion in secondary hemophagocytic lymphohistiocytosis

被引:0
作者
Wanying Cheng
Xin Gao
Guangli Yin
Jiayu Huang
Changfeng Man
Hongxia Qiu
机构
[1] The First Affiliated Hospital of Nanjing Medical University,Department of Hematology
[2] Jiangsu Province Hospital,Department of Geriatric Hematology
[3] The First Affiliated Hospital of Nanjing Medical University,undefined
[4] Jiangsu Province Hospital,undefined
来源
International Journal of Hematology | 2022年 / 116卷
关键词
Pleural effusion; Hemophagocytic lymphohistiocytosis; Prognostic;
D O I
暂无
中图分类号
学科分类号
摘要
The clinical features of patients with secondary hemophagocytic lymphohistiocytosis (sHLH) complicated with pleural effusion have rarely been evaluated. We retrospectively analyzed 203 patients newly diagnosed with sHLH from July 2015 to July 2019 according to the HLH-2004 protocol. Baseline characteristics, laboratory results, and imaging were reviewed. Pleural effusion was found in 58.6% of the studied sHLH population, and characteristic imaging findings were minimal volume and bilaterality. Patients with pleural effusion had lower PLT counts, HB levels and ALB levels as well as higher sCD25 levels than those without pleural effusion (all p values < 0.05). Multivariate analyses showed that lg(sCD25) and PLT ≤ 65 × 109/L were significant risk factors for developing pleural effusion in sHLH. Regarding prognostic value, survival analysis showed a lower survival probability for patients with pleural effusion than for those without pleural effusion (median OS, 90 vs. 164 days, p = 0.028). In multivariate analysis, pleural effusion was an independent prognostic factor for overall survival (OS) (HR 2.68; 95% CI 1.18–6.11, p = 0.019). Pleural effusion is frequently found in patients with sHLH and is associated with greater inflammation and worse outcomes.
引用
收藏
页码:102 / 109
页数:7
相关论文
共 137 条
  • [1] La Rosée P(2019)Recommendations for the management of hemophagocytic lymphohistiocytosis in adults Blood 133 2465-2477
  • [2] Horne A(2018)Hemophagocytic lymphohistiocytosis Annu Rev Pathol 13 27-49
  • [3] Hines M(2019)Hemophagocytic lymphohistiocytosis: clinical presentations and diagnosis J Allergy Clin Immunol Pract 7 824-832
  • [4] von Bahr GT(2020)Hemophagocytic lymphohistiocytosis: an update on pathogenesis, diagnosis, and therapy Best Pract Res Clin Rheumatol 34 101515-1516
  • [5] Machowicz R(2020)Adult haemophagocytic lymphohistiocytosis: a review QJM 14 hcaa011-1301
  • [6] Berliner N(2014)Adult haemophagocytic syndrome Lancet 383 1503-131
  • [7] Al-Samkari H(2016)Pulmonary involvement in patients with hemophagocytic lymphohistiocytosis Chest 149 1294-7259
  • [8] Berliner N(2007)HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis Pediatr Blood Cancer 48 124-674
  • [9] Risma KA(2012)The significance of 18F-FDG PET/CT in secondary hemophagocytic lymphohistiocytosis J Hematol Oncol 5 40-1555
  • [10] Marsh RA(2004)X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization Clin Cancer Res 10 7252-401